Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats

Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats

Objective : To investigate the combination of telmisartan with trandolapril therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in type 2 diabetes mellitus rats. Material and methods : Neonatal rats (2 days old) were used for inducing type 2 diabetes mellitus. Streptoz...

Full description

Bibliographic Details
Main Authors:	Ravi P Rao, AK Jain, BP Srinivasan
Format:	Article
Language:	English
Published:	Hindawi - SAGE Publishing 2011-09-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.1177/1470320310392097

Similar Items

The effects of dual and triple combinations of trandolapril, telmisartan, and verapamil on overt proteinuria in the patients with diabetic nephropathy
by: Bülent Albayrak, et al.
Published: (2016-01-01)

Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats
by: Ashish Kumar Sharma, et al.
Published: (2014-12-01)

Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
by: Samsu N, et al.
Published: (2019-08-01)

Trandolapril/verapamil combination in hypertensive diabetic patients
by: José A García Donaire, et al.
Published: (2007-03-01)

Prevalence of diabetic nephropathy in Type 2 Diabetes Mellitus in rural communities of Guanajuato, Mexico. Effect after 6 months of Telmisartan treatment
by: Priscyla Zenteno-Castillo, et al.
Published: (2015-12-01)

Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats.
by: Nora F Banki, et al.
Published: (2012-01-01)

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
by: Sanjib Kumar Sharma, et al.
Published: (2007-09-01)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
by: Steen Neldam, et al.
Published: (2013-01-01)

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
by: Singh AK, et al.
Published: (2021-07-01)

Diabetes mellitus and diabetic nephropathy in Peru
by: Percy Herrera-Añazco, et al.
Published: (2017-04-01)

Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Sang Youl Rhee, et al.
Published: (2017-10-01)

DIABETES MELLITUS, DIABETIC NEPHROPATHY, CHILDREN: CERTAINISSUES
by: A. P. Fomina
Published: (2017-03-01)

Pathomorphological picture of diabetic nephropathy in experimental diabetes mellitus
by: S O Filinova, et al.
Published: (2019-12-01)

Effect of Telmisartan Versus Captopril on Insulin Resistance in Hypertensive Type 2 Diabetic Patients
by: Adnan Ali Zainal, et al.
Published: (2014-12-01)

Thyroid Function In Type 2 Diabetes Mellitus and in Diabetic Nephropathy
by: Srinidhi Rai, et al.
Published: (2013-08-01)

ACE inhibitor trandolapril effectiveness in arterial hypertension
by: K. I. Tebloev, et al.
Published: (2008-04-01)

Update on the use of Trandolapril in the management of cardiovascular disorders
by: Ariel Diaz, et al.
Published: (2008-12-01)

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
by: Piero Ruggenenti, et al.
Published: (2010-01-01)

HPTLC METHOD DEVELOPMENT AND VALIDATION OF TRANDOLAPRIL IN BULK AND PHARMACEUTICAL DOSAGE FORMS
by: N. Sreekanth, et al.
Published: (2010-06-01)

HPTLC method development and validation of trandolapril in bulk and pharmaceutical dosage forms
by: N Sreekanth, et al.
Published: (2010-01-01)

Combination versus monotherapy with statins in patients with type 2 diabetes mellitus of high and very high cardiovascular risk
by: Y. A. Sorokina, et al.
Published: (2019-08-01)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
by: Lingfeng Yang, et al.
Published: (2021-08-01)

Study on the expression of AKT in Type II diabetes mellitus and diabetic nephropathy
by: Pei-Yu Lin, et al.
Published: (2018)

Risk factors of diabetic nephropathy in patients with type 2 diabetes mellitus
by: Weng Fong Li, et al.
Published: (2019)

The Frequency of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes Mellitus
by: Neda Mostofizadeh, et al.
Published: (2019-09-01)

Diabetic nephropathy and myocardial lesions in children with type 1 diabetes mellitus
by: Larisa Vasil'evna Kazakova, et al.
Published: (2009-09-01)

Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients
by: V V Petriy, et al.
Published: (2008-12-01)

Dual contrast CMR for evaluation of telmisartan and amlodipine combination therapy in the diabetic murine myocardial injury model
by: Kim Paul J, et al.
Published: (2013-01-01)

Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications
by: Pradeep Gadge, et al.
Published: (2018-01-01)

Effect Of Antioxidant To Progression Of Diabetic Nephropathy In Diabetic Rat
by: Ki Sung Kang, et al.
Published: (2012-06-01)

Diabetic nephropathy – complications and treatment
by: Lim AK
Published: (2014-10-01)

Chemical substances as risk factors of nephropathy in diabetes mellitus
by: Zofia Marchewka, et al.
Published: (2009-12-01)

The progression of nephropathy in non-insulin-dependent diabetes mellitus
by: Mackie, Alasdair David Ramsay
Published: (1998)

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
by: Dejager S, et al.
Published: (2012-05-01)

Soybeans Ameliolate Diabetic Nephropathy in Rats
by: Young Eun Choi, et al.
Published: (2010-01-01)

Adequate prevention and control of type 2 Diabetes Mellitus delay diabetic nephropathy
by: Idania Teresa Mora Lopez, et al.
Published: (2016-06-01)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
by: Daniel Nyarko Hukportie, et al.
Published: (2021-08-01)

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
by: Kevin M Wheelock, et al.
Published: (2017-01-01)

Awareness of diabetic nephropathy in patients with type 2 diabetes mellitus: the Indian scenario
by: Chirag Bansal, et al.
Published: (2018-05-01)

Role of Obesity in the Progression of Diabetic Nephropathy in Patients with Diabetes Mellitus (Literature Review)
by: S.U. Аhmedova, et al.
Published: (2016-09-01)